Crossmark

ABO and RhD blood group are not associated with mortality and morbidity in critically ill patients; a multicentre observational study of 29 512 patients

Crossref DOI link: https://doi.org/10.1186/s12871-022-01626-4

Published Online: 2022-04-02

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kander, Thomas

Bjurström, Martin F.

Frigyesi, Attila

Jöud, Magnus

Nilsson, Caroline U.
Funding

Funding for this research was provided by:

Lund University
License Information

Text and Data Mining valid from 2022-04-02

Version of Record valid from 2022-04-02
More Information

Article History

Received: 30 November 2021

Accepted: 22 March 2022

First Online: 2 April 2022

Declarations

:

: The study was approved by the National Ethical Review Board, Sweden, with registration numbers 2014/916 and 2018/866. As the study was exclusively observational, the National Ethical Review Board, Sweden waived the requirement to obtain any informed consent. All authors confirm that the study was performed following the Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below